C-arm cone-beam computed tomography-guided minimally invasive open excision of an osteoid osteoma undetectable on fluoroscopy: A case report

Higuchi, Takashi; Yamamoto, Norio; Hayashi, Katsuhiro; Takeuchi, Akihiko; Abe, Kensaku; Taniguchi, Yuta; Araki, Yoshihiro; Tsuchiya, Hiroyuki

doi:10.1016/j.ijscr.2019.06.062

Cited by 2 publications

(3 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The clinical outcomes of this study are comparable to that of a previous study. [ 12 ] Higuchi et al reported a case of successful resection under CBCT guidance for invisible osteoid osteoma by regular biplane fluoroscopy. [ 12 ] However, to the best of our knowledge, there is a lack of literature on CBCT-guided curettage for osteoid osteoma.…”

Section: Discussionmentioning

confidence: 99%

“…CBCT use reduces the risk of intraoperative infections, which may occur during transportation from the radiation facility. [ 12 ] Meanwhile, in conventional CT-guided excision, postoperative fracture, infection, hematoma, and nerve injury were reported as postoperative complications. [ 21 ] In a study of CT-guided resection of osteoid osteoma in the femur, 2 femoral fractures (4.8%) were reported.…”

Section: Discussionmentioning

confidence: 99%

“…[8][9][10] In addition, cone-beam computed tomography (CBCT) has been used for accurate tumor ablation, cryoablation, and resection of osteoid osteoma in a hybrid operating room. [11][12][13] Although there is an existing case report on CBCT-guided resection, [12] studies on CBCT-guided curettage are lacking. Therefore, the effectiveness of CBCT-guided curettage for osteoid osteoma remains unclear.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Intraoperative cone-beam computed tomography-guided curettage for osteoid osteoma

Tsuha,

Oshiro,

Mizuta

et al. 2023

Medicine

View full text Add to dashboard Cite

Recently, cone-beam computed tomography (CBCT)-guided surgeries have been developed for bone and soft tissue tumors. The present study aimed to evaluate the efficacy of CBCT-guided curettage for osteoid osteoma. Our study population included 13 patients who underwent primary curettage for osteoid osteoma using intraoperative CBCT in a hybrid operating room between April 2019 and November 2022. We collected the following data: sex, age, follow-up period, symptom onset to time of surgery, tumor size and location, length of skin incision, operating time, radiation dose, recurrence, postoperative complications, and visual analog scale for pain during the last follow-up. There were 10 male and 3 female patients, and the mean age was 25.0 years (range, 9–49 years). The mean follow-up period was 10.6 months (range, 0.4–24.0 months). The locations of the tumors were the proximal femur in 6 patients, the acetabular region in 2 patients, and the ilium, tibial shaft, calcaneus, cuboid, and talus in 1 patient each. The mean time of symptoms onset to surgery was 18.7 months (range, 2.3–69.9 months). The mean maximum diameter of the tumor was 5.9 mm (range, 3.5–10.0 mm). The mean length of the skin incision was 2.2 cm (range, 1.5–3.5 cm). The mean operating time was 96.9 minutes (range, 64–157 minutes). The mean dose of radiation was 193.2 mGy (range, 16.3–484.0 mGy). No recurrences, postoperative complications, and reoperation were observed in this study. All the patients reported 0 mm on the visual analogue scale for pain on the last follow-up. CBCT-guided curettage for osteoid osteoma was minimally invasive and reliable. This procedure can be effective for the treatment of lesions found in deep locations such as the pelvic bone and proximal femur or an invisible lesion that cannot be detected by regular fluoroscopy.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%